Enbrel

Type: Product
Name: Enbrel
First reported 23 mins ago - Updated 23 mins ago - 1 reports

Lupin gains after inking JV with Japanese firm

Lupin rose 0.86% to Rs 990.55 at 11:28 IST on BSE after the company said it signed a strategic joint venture agreement with Japan's Yoshindo Inc. The company made the announcement during trading hours today, 23 April 2014.Meanwhile, the BSE Sensex was ... [Published India Infoline - 23 mins ago]
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Amgen's CEO Discusses Q1 2014 Results - Earnings Call Transcript

Amgen, Inc. ( AMGN ) Q1 2014 Results Earnings Conference Call April 22, 2014 5:15 PM ETOperatorMy name is Marvin, and I’ll be your conference facilitator today for Amgen’s First Quarter Earnings Conference Call. All lines have been placed on mute to ... [Published Seeking Alpha - 1 hour ago]
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Infliximab or Adalimumab, Vs Abatacept, in Patients With RA

Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315–324 (1988).Aletaha D, Neogi T, Silman AJ et al. 2010 rheumatoid arthritis classification ... [Published General Medicine eJournal - 1 hour ago]
First reported 7 hours ago - Updated 2 hours ago - 1 reports

Pfizer Touts Positive Results in Phase III Psoriasis Trials

Tofacitinib met its efficacy endpoints of superiority over placebo at week 16 in adult patients with moderate-to-severe plaque psoriasis in two pivotal Phase III trials, Pfizer said Tuesday.The multi-site, randomized, double-blind, placebo-controlled ... [Published FDA News - 7 hours ago]
First reported 10 hours ago - Updated 8 hours ago - 2 reports

New Drugs Help Drive Amgen's Operating Income Up 18% in Q1

It was steady as she goes for one of the most decorated biopharmaceuticals in the U.S., Amgen ( NASDAQ: AMGN     ) , which reported solid top- and bottom-line growth in the first quarter following its acquisition of Onyx Pharmaceuticals, which closed ... [Published Motley Fool Discussion Boards - 8 hours ago]
First reported Apr 22 2014 - Updated 8 hours ago - 1 reports

Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog

Amgen Inc. (NASDAQ: AMGN[1]) is set to report first quarter 2014 results on Apr 22 after the market closes. Last quarter, the company had posted an earnings surprise of +10.37%. Let's see how things are shaping up for this announcement. Factors at Play ... [Published DailyMe.Com - Apr 22 2014]
Entities: Amgen Inc, XGEVA, Aranesp
First reported 10 hours ago - Updated 8 hours ago - 2 reports

Amgen profit falls on inventory draw downs; sales disappoint

(Adds analyst, company comment, sales details, updates shares) By April 22 (Reuters) - Amgen Inc on Tuesday reported lower-than-expected first quarter profit as sales of several key products fell short of Wall Street estimates, with its big-selling rheumatoid ... [Published Sharenet - 8 hours ago]
First reported 8 hours ago - Updated 8 hours ago - 1 reports

Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion

2014 Revenue and Adjusted EPS Guidance ReaffirmedTHOUSAND OAKS, Calif., April 22, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2014. Key results include:Total revenues increased 7 percent to $4,521 ... [Published FiercePharma - 8 hours ago]
First reported 10 hours ago - Updated 9 hours ago - 1 reports

Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion

The first quarter includes results for Onyx Pharmaceuticals, Inc., which was acquired on Oct. 1, 2013. Adjusted operating income increased 18 percent to $1,860 million, driven by a significant increase in the profitability of Enbrel ® following the end ... [Published Insurance News Net - 10 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

Amgen Revenue Misses Analysts’ Estimates on Enbrel Sales

Amgen Inc. (AMGN) , the world’s largestbiotechnology company by sales, reported first-quarter revenuebelow analysts’ estimates on lower-than-expected demand of itstop drug, Enbrel.Quarterly sales increased 6.6 percent to $4.52 billioncompared with a year ... [Published Bloomberg - 10 hours ago]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

The Prescription Drug Epidemic

A new report published Sunday by Natural Society says Americans consume 50% of the world's prescription drugs . That's a mind-blowing number, considering that Americans only make up 5 percent of the world population. This is the astonishing claim made ... [Published Examiner.com - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Composing only 5% of the world population, Americans take 50% of all pharmaceutical drugs

© Natural SocietyWhile Americans comprise only 5 percent of the world population, we consume an incredible 50 percent of Big Pharma's drugs, as explained in Jeff Hays' documentary film, Doctored . Make no mistake. These drugs are meant to keep us imprisoned ... [Published Sott.net - Apr 21 2014]

Quotes

...growth in adjusted operating income make us confident in our full-year growth outlook," said Robert A Bradway, chairman & chief executive officer. "We continue to advance our robust late stage pipeline and expect to submit global filings for evolocumab in 2014."
"Sadly, Americans are more familiar with names like Abilify, Nexium, Humira, Plavix, Crestor, Advair Diskus, Enbrel, and Cymbalta, the top selling drugs of Big Pharma, than names like Aloe barbadensis, Curcuma longa, Allium sativum, Moringa oleifera, Vitis vinifera L, all indigenous plants that have healed millions around the world" the report says
"' This could manifest, behaviorally, via magnified antioxidant and anti-inflammatory activity, reduction of intestinal permeability and the detrimental effects of LPS, improved glycemic control, positive influence on nutritional status (and therefore neurotransmission and neuropeptide production), direct production of GABA, and other bioactive chemicals, as well as a direct role in gut-to-brain communication via a beneficial shift in the intestinal microbiota itself.' In this way, we use bacteria to modify our own bacteria and subsequently dampen inflammatory signals."
The following quote was obtained by the news editors from the background information supplied by the inventors: "The present disclosure relates to an anti-tumor necrosis factor-alpha antibody (TNF-.alpha.), and in particular relates to a humanized monoclonal antibody which is capable of highly neutralizing tumor necrosis factor-alpha, and an amino acid sequence thereof."

More Content

All (223) | News (206) | Reports (0) | Blogs (13) | Audio/Video (0) | Fact Sheets (3) | Press Releases (1)
sort by: Date | Relevance
Lupin gains after inking JV with Japanese firm [Published India Infoline - 23 mins ago]
LT, Bharti, Sun Pharma lead gainers; Sensex gai... [Published Moneycontrol.com - 40 mins ago]
Amgen's CEO Discusses Q1 2014 Results - Earning... [Published Seeking Alpha - 1 hour ago]
Infliximab or Adalimumab, Vs Abatacept, in Pati... [Published General Medicine eJournal - 1 hour ago]
Pfizer Touts Positive Results in Phase III Psor... [Published FDA News - 7 hours ago]
New Drugs Help Drive Amgen's Operating Income U... [Published Motley Fool Discussion Boards - 8 hours ago]
Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen’s... [Published Jutia Group - 8 hours ago]
Amgen profit falls on inventory draw downs; sal... [Published Sharenet - 8 hours ago]
Amgen's First Quarter 2014 Revenues Increased 7... [Published FiercePharma - 8 hours ago]
Amgen Profit Falls 25% [Published RTTNews.com - 9 hours ago]
Amgen announces 7 percent revenue increase for ... [Published Ventura County Star - 10 hours ago]
UPDATE 1-Amgen profit falls on costs, disappoin... [Published CNBC - 10 hours ago]
Amgen Revenue Misses Analysts’ Estimates on Enb... [Published Bloomberg - 10 hours ago]
Amgen's First Quarter 2014 Revenues Increased 7... [Published Insurance News Net - 10 hours ago]
Dermatological Drugs Market Forecast 2014-2024 [Published Individual.com - 17 hours ago]
Global Ankylosing Spondylitis (Bekhterev's Dise... [Published Individual.com - 21 hours ago]
Will Amgen (AMGN) Miss This Earnings Season? - ... [Published DailyMe.Com - Apr 22 2014]
Will Amgen (AMGN) Miss This Earnings Season? - ... [Published Benzinga.com - Apr 22 2014]
What a Combined Pfizer and AstraZeneca Would Lo... [Published 24/7 Wall St - Apr 21 2014]
The Prescription Drug Epidemic [Published Examiner.com - Apr 21 2014]
Composing only 5% of the world population, Amer... [Published Sott.net - Apr 21 2014]
ASTRAZENECA : Top-selling drugs [Published 4 Traders - Apr 20 2014]
Psoriasis Market – Plaque Psoriasis & Psoriatic... [Published PRWeb - Apr 20 2014]
Composing Only 5% of the World Population, Amer... [Published PrisonPlanet - Apr 20 2014]
What’s keeping the generic version of biologic ... [Published PBS - Apr 19 2014]
Pfizer Inc (NYSE:PFE) – Pfizer Invites Public t... [Published Jutia Group - Apr 19 2014]
Buffett And Hedge Funds Love These 3 Stocks [Published Yahoo! Finance - Apr 19 2014]
The Efficacy of Anti-TNF Agents for Ulcerative ... [Published Diabetes Care - Apr 18 2014]
Earnings Roundup: Johnson & Johnson Results Are... [Published Motley Fool - Apr 17 2014]
Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen A... [Published Jutia Group - Apr 17 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Top 10 Wealthiest Athletes: Worldwide Endorseme... [Published Wall St. Cheat Sheet - Apr 14 2014]
Source: Thinkstock It’s an open secret that the real money in sports isn’t in the team contract or the winnings, but in the endorsement deals. This is ever since Honus Wagner first signed on with Hillerich & Bradsby in 1905, putting his replicated ...
Mickelson's PGA Standing vs. Enbrel's DTC Spending [Published Pharma Marketing Blog - Apr 12 2014]
Phil Mickelson, 5-over, missed the cut at the Masters this year. Bummer!Because of that, you might not see more Enbrel ads featuring Mickelson who is a hired gun - er, celebrity spokesperson - for the Enbrel brand (see "Amgen Blows Its Marketing Budget ...
A Second Lawsuit Tests the BPCIA Biosimilars “P... [Published FDA Law Blog - Apr 02 2014]
By Kurt R. Karst –Earlier this week, Celltrion Healthcare Co., Ltd. and Celltrion, Inc. (collectively “Celltrion”) filed a Complaint for Declaratory Judgment in the U.S. District Court for the District of Massachusetts seeking a judgment with respect ...
CRMO "Chronic Recurrent Multifocal Osteomyelitis" [Published HealthBoards - Apr 01 2014]
Our 11 year old daughter was diagnosed with CRMO this past October. It started out in her knees and has spread to new places. She's been on Methotrexate since last year and started Enbrel injections in February with no luck. She just started the Humira ...
Pfizer Announces Detailed Results of OPT Compar... [Published Business Wire Health News - Mar 22 2014]
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today detailed results from OPT Compare (A3921080), a Phase 3 study of tofacitinib, the first in a new class of treatment, oral Janus kinase (JAK) inhibitors, the safety and efficacy of which ...
1 2 3

Press Releases

sort by: Date | Relevance
Coherus maakt bekend dat CHS-0214 (Proposed Eta... [Published PR Newswire - Oct 29 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.